Practical COVID-19 Prevention Training for Obstetrics and Gynecology Residents Based on the Conceive-Design-Implement-Operate FrameworkRandomized Controlled Trial Published on 2022-03-032022-10-05 Journal: Frontiers in Public Health [Category] 임상, [키워드] addition adopted analyzed approach CDIO model China Clinical practice Combination control group control groups Course COVID-19 COVID-19 epidemic effective engineering education model ENhance Epidemic framework Gynecology identity IMPROVE Infectious disease infectious disease protection Intervention intervention group knowledge management obstetrics practical skills training prevention professional identity protocol provide randomly divided reduce required resident resident standardized training significantly significantly higher spread of COVID-19 statistical Stress training training model two group university was selected were assessed working pressure. [DOI] 10.3389/fpubh.2022.808084 PMC 바로가기 [Article Type] Randomized Controlled Trial
The unfavorable effects of COVID-19 on Dutch advanced melanoma care네덜란드 진행성 흑색종 치료에 대한 COVID-19의 불리한 영향Article Published on 2022-03-012022-09-12 Journal: International journal of cancer [Category] MERS, SARS, 진단, [키워드] Advanced melanoma affected baseline characteristics Brain Care Characteristics clinical outcomes control groups Course courses COVID-19 COVID-19 pandemic diagnosed Diagnosis Effect First wave Follow-up Frame geographical regions investigated Melanoma nationwide registry Netherland Netherlands outcomes P-value Patient performance status Region second wave selected significantly systemic therapy therapy Treatment [DOI] 10.1002/ijc.33833 PMC 바로가기 [Article Type] Article
Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Mild and Common-Type COVID-19: A Randomized, Controlled, Multicenter Clinical StudyResearch Article Published on 2022-02-102022-10-31 Journal: Evidence-based Complementary and Alternative Medicine : eCAM [Category] COVID-19, [키워드] adverse event Analysis carried Chest computed tomography Chinese clinical clinical symptom control group control groups Controlled coughing COVID-19 COVID-19 case COVID-19 patient Effect effective Effectiveness elevated Fever Laboratory median time Mild multicenter no difference participant Participants preliminary finding primary endpoint Randomized reduced Registered registry Result Safety symptom alleviation symptomatic Tablet tablets therapeutic time Treatment Trial undergo viral infections [DOI] 10.1155/2022/8733598 PMC 바로가기 [Article Type] Research Article
Use of remdesivir in patients with COVID-19: a systematic review and meta-analysisCOVID-19 환자의 렘데시비르 사용: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-02-022022-09-11 Journal: Revista da Sociedade Brasileira de Medicina Tropic [Category] COVID19(2023년), SARS, 치료제, [키워드] 95% CI adverse event adverse events Clinical improvement clinical trials clinically control group control groups controls COVID-19 COVID-19 patient eligibility criteria English Evidence extracorporeal membrane oxygenation had no mechanical ventilation membrane Meta-analysis moderate moderate to severe Mortality no significant difference no significant differences Observational cohort study outcomes Oxygenation pacientes com COVID-19 pacientes hospitalizado Patient patients hospitalized patients with moderate Phase 3 question randomizado randomized clinical trial RCT RCTs receiving Remdesivir retrieved risk risk difference selected severe COVID-19 shown statistically significant difference systematic review treat Treatment [DOI] 10.36416/1806-3756/e20210393 PMC 바로가기 [Article Type] Meta-Analysis
Evaluation of two RT-PCR techniques for SARS-CoV-2 RNA detection in serum for microbiological diagnosis미생물 진단을 위한 혈청 내 SARS-CoV-2 RNA 검출을 위한 2가지 RT-PCR 기법 평가Article Published on 2022-02-012022-09-11 Journal: Journal of virological methods [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] Admission collected control group control groups COVID-19 COVID-19 patient COVID-19 patients death detect diagnosed with COVID-19 Diagnosis evaluate gold gold standard hospital ICU implementation negative Negative predictive value Non-COVID-19 patients non-ICU non-ICU patient pandemic Patient PCR tests poor prognosis positive Positive predictive value Predictive value Presence retrospective cohort study RNA rRT-PCR rRT-PCR test RT-PCR SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 RNA detection sensitivity serum serum sample serum samples specificity value Viremia [DOI] 10.1016/j.jviromet.2021.114411 PMC 바로가기 [Article Type] Article
Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination항인지질항체 양성 환자의 항PF4 항체 생산은 코로나19 예방접종에 영향을 받지 않는다Article Published on 2022-02-012022-09-12 Journal: RMD Open [Category] MERS, 진단, [키워드] absence activate administration Affect aggregation antibodies antibody Antiphospholipid association Asymptomatic carriers cationic chemokine clinical manifestation clinical manifestations Control control groups COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines described ELISA heparin heparin-induced thrombocytopenia Immunoglobulin in vitro infections mRNA-based not affect not affected Patient patients patients with COVID-19 Platelet platelet activation positive Production serum subject syndrome systemic lupus erythematosus tested thrombosis titre Treatment vaccination [DOI] 10.1136/rmdopen-2021-001902 PMC 바로가기 [Article Type] Article
COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and SafetyArticle Published on 2022-01-212022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Administered Admission age anticancer BNT162b2 Cancer cancer patient Cancer patients clinical trial Comorbidity composed conditions conducted control group control groups coronavirus disease COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines death Department effective evaluate excluded Factor female patient healthy volunteer healthy volunteers hematological hematology high risk IgG titer institution intensive care intubation Italy median mRNA1273 North Old patients Older older patient Patient Patients with cancer Post-vaccine primary endpoint Rate reported Risk factors Safe Safety SARS-CoV-2 secondary endpoint Secondary endpoints Seroconversion Side effect significantly lower solid tumor solid tumors the patient Treatment two-dose regimen vaccination Vaccine Year [DOI] 10.3390/vaccines10020164 PMC 바로가기 [Article Type] Article
A Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative StudyOriginal Paper Published on 2022-01-042022-10-30 Journal: JMIR Formative Research [Category] COVID-19, [키워드] acceptance approach Comparative control group control groups COVID-19 Diagnosis effective Effectiveness Efficacy European evaluate evaluated facilitate feasibility feasible indicated Infection Intensive Intervention intervention group less objective participant polymerase chain Prevent reduce required resource Result risk of infection SARS-CoV-2 SARS-CoV-2 testing Self-sampling sensitivity simulation model specificity Telemedicine test strategy effectiveness [DOI] 10.2196/32564 PMC 바로가기 [Article Type] Original Paper
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study여성의 COVID-19 관련 결과와 항 결핵 약물의 연관성 없음 : 전국 코호트 연구Multicenter Study Published on 2022-01-012022-08-31 Journal: Osteoporosis international : a journal established [Category] MERS, SARS, 치료제, [키워드] 1:1 Admission Alter Analysis analyzed association bisphosphonate Bisphosphonates cohort study control groups control patient COVID-19 COVID-19 infection Denosumab diagnosed with COVID-19 drug drugs evaluate Hospitalization ICU ICU admission independent individual intensive care intensive care unit admission lower risk Ministry of Health Mortality mortality rate mortality rates multicenter Multivariate analysis not altered Older Osteoporosis outcome outcomes Patient patients with COVID-19 positive Primary outcome Primary outcomes receiving reported Result retrieved retrospective cohort risk teriparatide Teriparatide. Treatment treatment group was performed with COVID-19 women [DOI] 10.1007/s00198-021-06067-2 PMC 바로가기 [Article Type] Multicenter Study
Evaluating the efficacy of extracted squalene from seed oil in the form of microemulsion for the treatment of COVID-19: A clinical study코로나19 치료를 위한 마이크로에멀젼 형태의 종자유 추출 스쿠알렌 효능 평가: 임상 연구Controlled Clinical Trial Published on 2022-01-012022-09-11 Journal: Journal of medical virology [Category] 임상, 치료제, [키워드] Admission adverse effect adverse effects age baseline characteristics blinded change clinical study clinical trial Computed tomography Control control groups controls cough COVID-19 COVID-19 patient COVID-19 patients CT scan Efficacy emergency department evaluated Evaluating Fever Gender group High-resolution Infection Inflammation Intervention intravenous Laboratory test lung lymphocyte Lymphocyte count microemulsion nanostructure need for oxygen oxygen Oxygen therapy performed Potential treatment pumpkin seed oil required significantly squalene squalene. standard treatment study groups subjects therapy Treatment treatment group twice a day underlying diseases White blood cell White blood cells [DOI] 10.1002/jmv.27273 PMC 바로가기 [Article Type] Controlled Clinical Trial